Shopping cart
Angiotensin receptor blockers and drug–drug interactions
Author: Domenic A Sica
Source: Expert Opinion on Drug Safety, Volume 4, Number 1, 1 January 2005 , pp. 139-140(2)
Publisher: Informa Healthcare
Abstract:
The pharmacokinetic characteristics of the angiotensin receptor blocker class are such that significant drug–drug interactions are unlikely. Moreover, this drug class is devoid of relevant class-specific side effects. These features provide some of the basis for the excellent tolerance of drugs in this class.Keywords: angiotensin receptor blockers (ARBs); cytochrome P450 (CYP); drug–drug interactions; irbesartan; losartan
Document Type: Miscellaneous
DOI: http://dx.doi.org/10.1517/14740338.4.1.139
Publication date: 2005-01-01
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- ingentaconnect is not responsible for the content or availability of external websites
- In this: publication
- By this: publisher
- In this Subject: Pharmacology
- By this author: Domenic A Sica
Tools
Receive new issue alert
Latest TOC RSS FeedKey
Print this page